Home » Recalls vs. Enhancements Guidance Overreaches, Industry Tells U.S. FDA
Recalls vs. Enhancements Guidance Overreaches, Industry Tells U.S. FDA
July 2, 2013
A recent U.S. Food and Drug Administration draft guidance on distinguishing product recalls from product enhancements has met strong industry resistance, with many stakeholders asking the agency to withdraw the guidance and try again.
To View This Article:
Subscribe To International Medical Device Regulatory Monitor